Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03038100
Title A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (IMagyn050)
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

ovary epithelial cancer

peritoneal carcinoma

fallopian tube cancer

Therapies

Atezolizumab + Bevacizumab + Carboplatin + Paclitaxel

Bevacizumab + Carboplatin + Paclitaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.